Concepedia

Mary Kish

MK

4

Publications

456

Citations

4

H-Index

2003

Active since

Affiliations

Pfizer (United States)(Current)

Mary Kish is an author at Pfizer (United States) specializing in lipid chemistry, drug discovery, and lipid science.

Top concepts

Publications per year

2003–2010

4

Publications

4

A Combined Model for Predicting CYP3A4 Clinical Net Drug-Drug Interaction Based on CYP3A4 Inhibition, Inactivation, and Induction Determined in Vitro

Odette A. Fahmi, Tristan S. Maurer, Mary Kish et al. · Drug Metabolism and Disposition · 2008 · 198 citations

Cytochrome P450 3A4 mRNA Is a More Reliable Marker than CYP3A4 Activity for Detecting Pregnane X Receptor-Activated Induction of Drug-Metabolizing Enzymes

Odette A. Fahmi, Mary Kish, Sherri Boldt et al. · Drug Metabolism and Disposition · 2010 · 134 citations

PREDICTION OF DRUG-DRUG INTERACTIONS FROM IN VITRO INDUCTION DATA

Odette A. Fahmi, Sherri Boldt, Mary Kish et al. · Drug Metabolism and Disposition · 2008 · 88 citations

Pyrrolopyrazinedione-Based Inhibitors of Human Hormone-Sensitive Lipase

Deborah H. Slee, Abhijit Bhat, Truc N. Nguyen et al. · Journal of Medicinal Chemistry · 2003 · 36 citations · Full text

, , +13

Rows per page

1–4 of 4